These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12239745)

  • 21. Validation study of the Victorian Birth Defects Register.
    Riley M; Phyland S; Halliday J
    J Paediatr Child Health; 2004; 40(9-10):544-8. PubMed ID: 15367149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The health status of southern children: a neglected regional disparity.
    Goldhagen J; Remo R; Bryant T; Wludyka P; Dailey A; Wood D; Watts G; Livingood W
    Pediatrics; 2005 Dec; 116(6):e746-53. PubMed ID: 16263972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program.
    Riehle-Colarusso T; Strickland MJ; Reller MD; Mahle WT; Botto LD; Siffel C; Atkinson M; Correa A
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):743-53. PubMed ID: 17990334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence is the preferred measure of frequency of birth defects.
    Mason CA; Kirby RS; Sever LE; Langlois PH
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):690-2. PubMed ID: 16240384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residential mobility patterns and exposure misclassification in epidemiologic studies of birth defects.
    Canfield MA; Ramadhani TA; Langlois PH; Waller DK
    J Expo Sci Environ Epidemiol; 2006 Nov; 16(6):538-43. PubMed ID: 16736057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program.
    Cragan JD; Gilboa SM
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):20-9. PubMed ID: 19089857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prepregnancy obesity as a risk factor for structural birth defects.
    Waller DK; Shaw GM; Rasmussen SA; Hobbs CA; Canfield MA; Siega-Riz AM; Gallaway MS; Correa A;
    Arch Pediatr Adolesc Med; 2007 Aug; 161(8):745-50. PubMed ID: 17679655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organizing population data into complex family pedigrees: application of a second-order data linkage to state birth defects registries.
    Tu S; Mason CA
    Birth Defects Res A Clin Mol Teratol; 2004 Sep; 70(9):603-8. PubMed ID: 15368560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles.
    Lin AE; Rasmussen SA; Scheuerle A; Stevenson RE
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):69-75. PubMed ID: 19107957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating genetic analyses into birth defects cluster investigations: strategies for identifying candidate genes.
    Green RF; Moore C
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):798-810. PubMed ID: 17036308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for investigating clusters of health events.
    MMWR Recomm Rep; 1990 Jul; 39(RR-11):1-23. PubMed ID: 2117247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Texas Birth Defects Registry: an active surveillance system.
    Miller E
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):787-92. PubMed ID: 17094140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic approaches to identifying environmental causes of birth defects.
    Dolk H
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):4-11. PubMed ID: 14755428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?
    Scheuerle A; Vannappagari VX; Miller MK
    Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):611-20. PubMed ID: 19215016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
    Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Framework for the development of response protocols for public health syndromic surveillance systems: case studies of 8 US states.
    Uscher-Pines L; Farrell CL; Babin SM; Cattani J; Gaydos CA; Hsieh YH; Moskal MD; Rothman RE
    Disaster Med Public Health Prep; 2009 Jun; 3(2 Suppl):S29-36. PubMed ID: 19491585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data collection for sexually transmitted disease diagnoses: a comparison of self-report, medical record reviews, and state health department reports.
    Niccolai LM; Kershaw TS; Lewis JB; Cicchetti DV; Ethier KA; Ickovics JR
    Ann Epidemiol; 2005 Mar; 15(3):236-42. PubMed ID: 15723771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of prenatal diagnostic procedures in pregnancies affected with birth defects, Hawaii, 1986-2002.
    Forrester MB; Merz RD
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):778-80. PubMed ID: 17019733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
    Jenkins MM; Rasmussen SA; Moore CA; Honein MA
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.